News

Eli Lilly in licensing pact with Alchemab for ALS program
Eli Lilly (LLY) inks a licensing agreement with Alchemab to jointly develop an ALS drug in a $415M deal. Read more here.
Fierce Biotech16h
Eli Lilly licenses early-stage ALS drug program from Alchemab in $415M pact
Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...
sf11h
Treasure Island Development Authority
Contact us for noise or dust caused by Treasure Island or Yerba Buena Island development construction. Learn about current on-Island construction impacts Information about current transit and ...